Australia’s first targeted treatment for the most common inherited heart disease is now reimbursed on the Pharmaceutical Benefits Scheme (PBS)
Australia’s first targeted treatment for the most common inherited heart disease is now reimbursed on the Pharmaceutical Benefits Scheme (PBS)
Australia’s first targeted treatment for the most common inherited heart disease is now reimbursed on the Pharmaceutical Benefits Scheme (PBS) New Australian research reveals more than 60,000, or 1 in 400 Australians are living with…
